Professional Documents
Culture Documents
Keywords: Optic nerve, Blood supply, Ischemic optic neuropathy (ION), Anterior ischemic optic neuropathy
(AION), Posterior ischemic ootic neuropathy (PION)
Abstract
Ischemic optic neuropathy (ION), based on vascular anatomy of the optic nerve, pathogenesis and clinical pic-
ture, consists of two distinct entities: anterior (AION) and posterior (PION) ischemic optic neuropathies. AION is
due to interference with posterior ciliary artery supply to the optic nerve head and retrolaminar part of the optic
nerve; it initially presents with visual loss and optic disc edema which progresses to optic atrophy in a month
or two. PION is due to occlusion of nutrient arteries to the posterior part of the optic nerve; in this condition
during the initial stages the optic disc is normal in spite of marked visual loss, but the atrophy develops later on.
Their pathogeneses, causes, clinical pictures, diagnosis and management are discussed briefly.
Ischemic optic neuropathy (ION) is a severe blinding The posterior ciliary arteries (PCAs) (directly or via
disease, with sudden onset of blindness at first in one the peripapillary choroid) are the only source of
eye and then after a variable interval usually in the supply to the lamina cribrosa and prelaminar regions
second eye. The erroneous impression that it is a rare and the main (if not the only) source to the retro-
disease is essentially based on frequent misdiagnosis laminar region, and they may also supply the tempo-
and lack of adequate knowledge on the subject. This ral part of the surface nerve fiber layer (10, 11, 12,
paper is primarily designed to create an awareness 16) (Fig. 1). The PCAs are therefore extremely im-
of this visually crippling disease, and its early diagnosis portant in the blood supply to the anterior part of
and adequate management. the optic nerve; this is the crucial factor to be recog-
nized in the pathogenesis of acute ischemia of this
part of the nerve. There are usually two or three
Blood supply of the optic nerve
PCAs (designated medial and lateral PCAs) arising from
the ophthalmic artery (9). The blood supply to this
To understand the pathogenesis and clinical picture
region is segmental, producing segmental ischemia
of ION, it is essential to know the exact arterial blood
in the event of occlusion of the corresponding PCA
supply of the optic nerve. Following is a very brief
or one of its subdivisions.
account of this. F o r this purpose the optic nerve
can be divided into two parts:
Anterior part o f the optic nerve * Some of the figures have been reproduced by courtesy of
the British Journal of Ophthalmology (Figs. 2, 5, 7), American
Academy of Ophthalmology and Otolarngology (Fig. t) and
This consists of the optic nerve head and the retro- Springer-Verslag (Fig. 8). This investigation was supported by
laminar region (i.e., part behind the lamina cribrosa), Public Health Service Grant EY-01151.
10
Terminology
cause and may involve not only the elderly and the
middle-aged but even the juvenile d i a b e t i c - a fact not
adequately stressed in the past. Among the less fre-
quent causes are systemic arterial hypertension or
hypotension, collagen vascular diseases, and other
systemic or local diseases associated with microvascu-
lar occlusive disorders. AION may also be due to
ocular causes, e.g., raised intraocular pressure or
other factors producing precipitous fall of perfusion
pressure in the anterior part of the optic nerve,
and lesions compressing the blood vessels to this
part of the nerve. In a number of cases it may not
be possible to be definite about the cause of ION
because of the limitations in the diagnostic tech-
niques.
Clinical picture
Apart from the ocular findings there may be systemic mal segment would give a false negative result (1,
abnormalities indicative of the causative systemic 18); in m y series of about a hundred patients with
disease. Thus it is essential to do systemic evaluation AION so far I have had no reasons to believe that
o f the patient to find out the cause o r l O N . there has been a false negative temporal artery
biopsy. As a result of this, I am of the opinion that
in patients with temporal arteritis and AION, the
Diagnosis chances of having a false negative temporal artery
biopsy are extremely small.
In a patient with ION, the first important step is It has been suggested by some observers that carotid
to rule out the presence o f temporal arteritis because angiography should be performed in these patients
of the potential danger of bilateral total b l i n d n e s s - (21). I feel there is no need to subject the vast
observance o f this fact can prevent many tragic blind- majority of patients with AION to such a procedure,
nesses. This can be done by doing an emergency because the chances of finding any helpful infor-
estimation of the erythrocyte sedimantation rate mation from it are so small that it does not justify
(ESR) in these patients. The question of normal the hazards involved; it should only be done if there
ESR in elderly persons is highly controversial. In m y is an evident carotid artery abnormality clinically.
series of patients with AION and confirmed temporal O p h t h a l m o d y n a m o m e t r y routinely has also been
arteritis (on biopsy of the superficial temporal artery) suggested in these patients (21). It is not only an
the ESR has varied from 21 to 135 (mean 85) m m / unreliable and unreproducible test but also does
hour by the Westergren method although in extremely not give any useful information in the vast majority
rare instances some authors have reported an ESR as about the state of circulation in the PCAs, because
low as 13, 12 and even 6 m m / h o u r (2, 3, 4, 17, 20). AION is not due to occlusion of the central retinal
In m y patients with AION and a negative temporal artery but to involvement of the P C A s - a normal
artery biopsy for temporal arteritis, the ESR varied ophthalmic artery pressure does not rule out PCA
from 1 to 115 (mean 22) mm/hour. This indicates and small optic nerve vessel disease and vice versa.
that while elevated ESR is highly suggestive of tem- As mentioned earlier, a systemic evaluation of a
poral arteritis, a normal ESR in the elderly does patient with ION is extremely important, for both
not rule out temporal arteritis. Small and Gavrilles- diagnosis and management of these patients.
cu (23) showed the presence of serum C-reactive
the ESR has varied from 21 to 135 (mean 85) m m /
hour by the Westergren m e t h o d although in extremely Differential diagnosis
rare instances some authors have reported an ESR as
low as 13, 12 and even 6 ram/hour (2, 3, 4, 17, 20). It depends upon whether the patient is seen soon
and in assessing the activity of the disease. This after onset of AION (i.e., with optic disc edema)
requires further exploration. or late (i.e., with optic atrophy). If an elderly indivi-
Biopsy o f the superficial temporal artery should be dual is seen with a history of sudden loss of vision
performed in all cases suspected of temporal arteritis and optic disc related visual field defects with (i)
to establish the diagnosis; since temporal arteritis unilateral optic disc edema, or (ii) optic disc edema
is in fact a systemic disease, general symptoms in one eye and optic atrophy in the fellow eye, or
(e.g., malaise, weakness, muscular and joint pains, (ii) bilateral optic atrophy, the diagnosis is AION
anorexia, fever, etc.) and headache, particularly in unless proved otherwise. A lack of appreciation of
the temporal region, may be helpful in suggesting these facts has resulted in not only wrong diagnosis
the disease. The presence of euphoria in these pa- but also unnecessary, hazardous, time consuming
tients or of the occult variety of the disease may mis- and expensive neuro-surgical investigations. In diabe-
lead the physician. Recently some investigators tics of any age, if the disc is swollen and there are
have indicated the presence of normal areas in a disc related visual field defects, AION must be con-
superficial temporal artery otherwise involved by sidered as a most probable cause; diabetics get a par-
giant cell arteritis, so that a section through the nor- ticularly rough deal from ophthalmologists because
Ischemic optic neuropathy 17
any visual loss in them tends to be attributed to dia- betes by a diabetes specialist-without such strict
betic retinopathy and the patient tragically may be control this therapy should not be given.
treated with panretinal photocoagulation under the 4. A I O N due to causes other than vasculitis: Most of
erroneous impression that the prominent vessels the patients with AION fall in this category, where,
on the optic disc represent neovascularization. In apart from arteriosclerosis and atherosclerosis, there
collagen vascular diseases, a sudden loss of vision is no evident abnormality. Their management is
with a normal fundus during the early stages must highly controversial. Most physicians do not treat
be considered due to PION unless proved otherwise. them, and dismiss them with a philosophical advice to
It is beyond the scope of this paper to go into any accept blindness as an 'act of God'. However, there
more details on the differential diagnosis of ION. are some reports suggesting that systemic corticoster-
oids in high doses during the initial stages of the dis-
ease (i.e., with optic disc edema) have a beneficial
Treatment effect in a significant number of these patients
(5, 7, 15, 16).
The management of ION can be divided into the fol- I would like to emphasize very strongly that if sys-
lowing categories: temic corticosteroid therapy is to show beneficial
1. 1ON due to temporal arteritis: This is an ocular effect in categories 2, 3 and 4 above, the treatment
emergency. If in doubt, AION in persons over the age must be instituted as early as possible, while the optic
of 60 years should be regarded as due to temporal disc still shows a fair amount o f edema, starting
arteritis, particularly if a patient suddenly develops with at least 80 mg prednisone daily and maintained
attacks of transient altitudinal hemianopic amaurosis on adequate doses (not less than 40 mg. daily) so
or sudden complete blindness in an eye preceded b y long as the disc shows edema (which lasts at the maxi-
attacks of transient amaurosis. The treatment is to
mum for 4-8 weeks from its onset). Once the disc
institue therapy immediately with systemic corticos-
has become atrophic, no treatment is worthwhile.
teroids in adequately high doses, e.g., prednisone
Since the treatment is given for not more than 4-6
80-100 mg or even more daily. The object of the
weeks at the maximum, none of the serious side-
treatment is to prevent the loss of vision in the
effects associated with long-term steroid therapy are
second eye. Occasionally the treatment may produce
seen in the vast majority except those with diabetes
some visual recovery which tends to be insignificant.
meUitus (see above). Since the whole of this treat-
Dosage and duration of therapy is guided by the ESR
ment is somewhat controversial, we are at present
level. These patients require prolonged steroid ther-
conducting a double masked randomized therapeutic
apy, usually for years, and suddenly reducing or
trial with systemic corticosteroids versus placebo
stopping the drug prematurely may produce visual
to evaluate further the role of this therapy in AION.
symptoms in the normal eye and a rise of ESR.
In addition to this, I feel every attempt should be
2. I O N due to collagen vascular disease: These pa-
made to reduce the intraoccular pressure to as low
tients should be treated by high doses of systemic a level as possible in patients with AION, with a view
corticosteroids during the initial stages of the disease. improve perfusion pressure in the optic disc vessels
In m y experience there is a significant recovery of (Perfusion pressure = Mean Blood pressure minus
visual function in some of these patients after an intraocular pressure).
early and adequate corticosteroid therapy.
3. A I O N with diabetes mellitus: There is no weU-
established treatment available for this category. In Prophylactic measures against ION
m y experience so far there has been a significant
recovery of visual function on treatment with high Since ION, particularly in temporal arteritis, is a
doses of systemic corticosteroids during the initial blinding disease with poor prognosis for recovery
stages of the disease when the disc is edematous. o f vision, and with a high risk of the second eye
The steroids aggravate the diabetes and these patients being involved after the first, it is worthwhile to con-
require very stringent inpatient control o f their dia- sider the possible preventive measures that could
18 Sohan Singh Hayreh
be taken to lower the incidence of blindness due to 19. Lancet. Editorial on 'C-reactive protein or E.S.R.?'
ION. These are discussed at length elsewhere (16). Lancet 2:1166 (1977).
20. Permin, H., F. Juhl, A. Wiik & J. Balslov. Immunoglo-
Briefly these consist of early diagnosis of temporal bniin deposits in the dermo-epidermal junction zones
arteritis, i.e., before ocular symptoms develop, and, in patients with systemic lupus erythematosus.
Rheumatoid arthritis and temporal arteritis compared
if a patient has ION in one eye, therapy should be
by serological testing including a2 -macroglobniin.
started immediately even if the diagnosis of temporal Scand. J. Rheum 6:105-110 (1977).
arteritis is not conclusive. 21. Sanders, M.D.s Neurol. Sci. 31:308 (1977).
22. Singh, S. & R. Dass. The central artery of the retina.
II. A study of its distribution and anastomoses. Br. d.
OphthaL 44: 280-229, (1960).
23. Small, J.M. & K. Gavrilescu. The serum protein changes
References
in giant cell arteritis. J. Neurol. Neurosurg. Psychiat.
26:257-261 (1963).
1. Albert, D.M., M.C. Ruchman & J.L. Keltner. Skip areas
in temporal arteritis. Arch. Ophthal. (Chicago) 94:
2072-2077 (1976).
2. Bethlenfalvay, N.C. & M.L. Nusynowitz. Temporal Author's address:
arteritis, a rarity in the young adult. Arch. Inter. Med. University of Iowa Hospitals and Clinics
114:487-489 (1964). Iowa City, Iowa 52242
3. Cullen, J.F. Occult temporal merits. Trans. Ophthal. USA
Soc. U.K. 83:725-736 (1963).
4. Eagling, E.M., M.D. Sanders & S.J.H. Miller. Ischaemic
papillopathy. Br. J. Ophthal. 5 8 : 9 9 0 - 1 0 0 8 (1974).
5. Foulds, W.S. Visual disturbances in systemic disorders
- optic neuropathy and systemic disease. Trans.
Ophthal. Soe. U.K. 89:125-146 (1969).
6. Francois, J. Les pseudo-papillites vasculalres. Rapport
Soc. fran~. Ophtal. (1956).
7. Georgiades, G., N. Stangos &E. lliadelis. The anterior
ischemic opticopathy or vascular pseudothilitis. Ophthal.
Chron. (Athens) 13:32-56 (1976).
8. Hayreh, S.S. A study of the central artery of the retina
in human beings. Thesis for Master of Surgery. Panjab
University, India (1958).
9. Hayreh, S.S. The ophthalmic artery - III. Branches.
Br. J. Ophthal. 46:212-247 (1962).
10. Hayreh, S.S. Blood supply in the optic nerve head and
its role in optic atrophy, glaucoma and oedema of the
optic disc. Br. J. Ophthal. 53:721-748 (1969).
11. Hayreh, S.S. Pathogenesis of visual field defects - role
of the ciliary circulation. Br. J. Ophthal. 54: 289-
311 (1970).
12. Hayreh, S.S. Anatomy and physiology of the optic
nerve head. Trans. Am. Acad. Ophthal. Otolaryng.
7 8 : 0 P - 2 4 0 - 2 5 4 (1974a).
13. Hayreh, S.S. Anterior ischaemic optic neuropathy -I.
Temainology and pathogenesis. Br. J. Ophthal. 58:
955-963 (1974h).
14. Hayreh, S.S. Anterior isehaemic optic neuropathy-lI.
Fundus on ophthalmoscopy and fluorescein angiogra-
phy. Br. J. Ophthal. 58:964-980 (1974c).
15. Hayreh, S.S. Anterior ischaemic optic neuropathy-III.
Treatment, prophylaxis, and differential diagnosis.
Br. J. Ophthal. 58: 981-989, (1974 d).
16. Hayreh, S.S. Anterior ischemie optic neurophaty.
Springer-Verlag, New York (1975).
17. Kansu, T., J. Corbett, P. Savino & N. Schatz. Giant
cell arteritis with normal sedimentation rate. Arch.
Neurol. (Chicago) 34: 624-625 ( 1977 ).
18. Klein, R.G., R.J. CampveU, G.G. Hunder & J.A. Car-
ney. Skip lesions in temporal arteritis. Mayo Clin.
Proc. 51:504-510 (1976).